1,4-Dichlorobenzene

1,4-Dichlorobenzene

SCHEMBL76049

CC(=O)O.Clc1ccc(Cl)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of 1,4-Dichlorobenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.60
TSHR P16473 1/20 0.60
CES2 O00748 3/20 0.55
CES1 P23141 3/20 0.55
LMNA P02545 1/20 0.53
CYP2A6 P11509 1/20 0.53
SRD5A2 P31213 1/20 0.52
BRD4 O60885 1/20 0.52
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CYP2C9 P11712 2/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
PPARA Q07869 1/20 0.48
FFAR3 O14843 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Parachlorophenol SCHEMBL3273837 0.89 MAPK1 (0.62) ALOX15TSHRCES2CES1SRD5A2
Chlorobenzene SCHEMBL4166598 0.88 TSHR (0.65) ALOX15TSHRCES2CES1LMNA
Acetic Acid SCHEMBL28400035 0.87 ALOX15 (0.48) ALOX15TSHRCES2CES1LMNA
4-Chloroaniline SCHEMBL7836943 0.87 MEN1 (0.52) ALOX15TSHRCES2CES1LMNA
4-Chloro-Benzoic Acid SCHEMBL6444124 0.87 TSHR (0.85) ALOX15TSHRCES2CES1SRD5A2
Acetic Acid SCHEMBL28930218 0.87 ALOX15 (0.48) ALOX15TSHRCES2CES1LMNA
Acetic Acid SCHEMBL7439099 0.87 ALDH1A1 (0.50) ALOX15TSHRCES2CES1LMNA
1,4-Dichlorobenzene SCHEMBL28270431 0.86 TSHR (0.67) ALOX15TSHRCES2CES1LMNA
1,4-Dichlorobenzene SCHEMBL28270432 0.86 TSHR (0.67) ALOX15TSHRCES2CES1LMNA
Chlorobenzene SCHEMBL27974158 0.85 TSHR (0.61) ALOX15TSHRCES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105566219-B The manufacturing method and its manufacture intermediate of 3,4- dihydroisoquinoline derivatives 三井化学AGRO株式会社 2019-03-01 CN disclosed
CN-105439951-B The manufacturing method of the manufacture intermediate of 3,4- dihydroisoquinoline derivatives 三井化学AGRO株式会社 2018-07-06 CN disclosed
CN-107759460-A A kind of method for preparing the more acid monomers of polyphenyls 朱翠英 2018-03-06 CN disclosed
EP-1919857-B1 PROCESS FOR THE SYNTHESIS OF MANDIPROPAMID AND DERIVATIVES THEREOF SYNGENTA PARTICIPATIONS AG (CH) 2016-03-09 EP disclosed
CN-102459187-B Janus Kinase Inhibiting Compounds and Methods HOFFMANN LA ROCHE 2015-06-17 CN disclosed
CN-104591973-A Preparation method of 2,5-dichlorophenol ANHUI SEALONG BIOTECHNOLOGY CO LTD 2015-05-06 CN disclosed
CN-104592022-A Method for preparing 2, 5-dichlorobenzene acetate ANHUI SEALONG BIOTECHNOLOGY CO LTD 2015-05-06 CN disclosed
CN-104592022-A Method for preparing 2, 5-dichlorobenzene acetate ANHUI SEALONG BIOTECHNOLOGY CO LTD 2015-05-06 CN disclosed
CN-102459187-A Janus Kinase Inhibiting Compounds and Methods HOFFMANN LA ROCHE 2012-05-16 CN disclosed
US-8129560-B2 Process for the synthesis of mandipropamid and derivatives thereof SYNGENTA CROP PROTECTION, INC. (US) 2012-03-06 US disclosed
US-20090118532-A1 Process for the Synthesis of Mandipropamid and Derivatives Thereof SYNGENTA CROP PROTECTION, INC. (US) 2009-05-07 US disclosed
EP-1919857-A2 PROCESS FOR THE SYNTHESIS OF MANDIPROPAMID AND DERIVATIVES THEREOF Syngeta Participations AG (CH) 2008-05-14 EP disclosed
WO-2007020381-A2 PROCESS FOR THE SYNTHESIS OF MANDIPROPAMID AND DERIVATIVES THEREOF SYNGENTA PARTICIPATIONS AG (CH) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118532-A1 Process for the Synthesis of Mandipropamid and Derivatives Thereof OPRM1, OPRD1, ADRA1D ALOX15 993/4885TSHR 272/4885CES2 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.